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The Belgrade rat is an animal model of divalent metal transporter 1 (DMT1) deﬁciency.
This strain originates from an X-irradiation experiment ﬁrst reported in 1966. Since
then, the Belgrade rat’s pathophysiology has helped to reveal the importance of iron
balance and the role of DMT1. This review discusses our current understanding of
iron transport homeostasis and summarizes molecular details of DMT1 function. We
describe how studies of the Belgrade rat have revealed key roles for DMT1 in iron
distribution to red blood cells as well as duodenal iron absorption. The Belgrade rat’s
pathology has extended our knowledge of hepatic iron handling, pulmonary and olfac-
tory iron transport as well as brain iron uptake and renal iron handling. For example,
relationships between iron and manganese metabolism have been discerned since
both are essential metals transported by DMT1. Pathophysiologic features of the Bel-
grade rat provide us with a unique and interesting animal model to understand iron
homeostasis.
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OVERVIEW OF IRON HOMEOSTASIS
Iron is present in hemoproteins, such as the important oxygen
carriers hemoglobin and myoglobin, and it is a component of
non-heme proteins that carry out other key functions in cellular
metabolism, such as mitochondrial aconitase and ribonucleotide
reductase. The relevance of iron lies in its ability to cycle reversibly
between the ferrous (Fe2+) and the ferric (Fe3+) oxidation states
(Wessling-Resnick, 1999). Free ferrous iron is a potent catalyst for
lipid peroxidation andprotein andDNAoxidation since it is able to
react with molecular oxygen and generate reactive oxygen species
(ROS) through Fenton chemistry (Hentze et al., 2004) Given the
biological importance of iron and the potential for its toxicity, iron
homeostasis is tightly regulated.
Dietary iron is absorbed through the duodenum. Regulated
pathways of iron excretion do not appear to exist, and therefore
regulation of iron absorption is critical to maintain iron bal-
ance. Iron reaches the liver by portal circulation, where it can
be stored until needed or delivered through systemic circulation
to peripheral tissues. A signiﬁcant amount of iron is transported
to the bone marrow where erythropoiesis takes place. Senescent
red blood cells (RBCs) are phagocytosed by reticuloendothelial
macrophages, which catabolize iron from heme to be recycled
and used for new RBC synthesis. This recovery is highly efﬁ-
cient so that most of the body iron is usually found in circulating
hemoglobin within erythrocytes (Wessling-Resnick, 2000; Hentze
et al., 2004).
Duodenal absorption of iron begins at the apical membrane of
enterocytes, where the reduction of Fe3+ to Fe2+ is carried out
by DcytB and possibly other ferrireductases (McKie et al., 2001;
Mackenzie and Garrick, 2005). Then, iron is transported into the
cell through its primary importer DMT1 [divalent metal trans-
porter 1; SLC11A2 (solute carrier family 11, member 2); DCT1
(divalent cation transporter 1)]. Once iron enters the cell it may
be stored in ferritin, a protein complex constituted by heavy and
light chains that is able to store up to 4500 iron atoms (Harrison
and Arosio, 1996). Iron can also be immediately exported from
the cell by ferroportin [Fpn; SLC40A1; MTP1 (metal transporter
protein 1)], which is located in the basolateral membrane of ente-
rocytes (Abboud and Haile, 2000; Donovan et al., 2000; McKie
et al., 2000). The ferroxidase hephaestin mediates its conversion to
the ferric state before it is released and bound by serum transferrin
(Tf; Wessling-Resnick, 2006). Figure 1 summarizes the elements
involved in this process.
At the site of liver iron storage, hepatocytes take up iron through
two distinct pathways. Tf-bound iron is taken by the Tf cycle
(Figure 2). In this pathway, iron-loaded Tf binds to its receptor
on the cell surface at neutral pH. After binding, the complex is
internalized by receptor-mediated endocytosis, entering an endo-
somal compartment that is acidiﬁed by a proton pump. This
acidiﬁcation enables release of iron from Tf and its subsequent
transport out of the endosome through DMT1. Subsequently,
the apo-Tf–Tf receptor (TfR) complex returns to the cell sur-
face to dissociate at neutral pH (Dautry-Varsat et al., 1983). There
are two TfRs that have been characterized: TfR1 is ubiquitously
expressed while TfR2 is only expressed in certain tissues, including
the liver. Hepatocytes are also capable of importing non-Tf-bound
iron (NTBI), which accumulates in circulation during iron load-
ing conditions such as hereditary hemochromatosis. Although
DMT1 might be one route for NTBI uptake (Shindo et al., 2006),
a member of the SLC39 ZIP family called Zip14 may play a more
important role in this process (Liuzzi et al., 2006; Nam et al.,
2013; Wang and Knutson, 2013). Once inside of the cell, the
iron can be stored as ferritin or released back into the circula-
tion in response to deﬁciency conditions. The latter process is
thought to involve iron export by ferroportin (Wessling-Resnick,
2006).
Because most of the body’s iron is found in hemoglobin, ery-
throcytes are especially important in iron handling. Erythroid
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FIGURE 1 | Intestinal iron uptake. Luminal ferric iron is reduced (DcytB) at
the apical membrane of enterocytes. Ferrous iron is then transported into
the cell by the brush border protein DMT1. Once inside the cell, iron can
bind to ferritin to be stored or exported across the basolateral surface by
FPN. The ferroxidase hephaestin converts it into the ferric form. Ferric iron
is bound by apo-Tf to circulate into the blood.
precursors take up iron by the Tf cycle in a highly efﬁcientmanner;
they probably lack an iron export mechanism since all the iron is
retained by the cell, intended for hemoglobin synthesis (Andrews,
2000). The release of iron from the endocytic compartment
requires functional DMT1 in these cells (Fleming et al., 1998).
A ferrireductase, Steap3, acts to reduce Fe3+ to Fe2+, enabling
transport to the cytosol (Ohgami et al., 2005). Iron entering the
erythron goes to the mitochondria where the major proportion
of intracellular iron metabolism takes place (Garrick and Garrick,
2009).
Although iron homeostasis mainly relies on the control of
iron efﬂux from duodenal enterocytes and iron reutilization by
macrophages balanced by the demands of heme synthesis byRBCs,
increasing data suggest that the kidney could also be involved
in systemic iron handling (Moulouel et al., 2013; Veuthey et al.,
2013). DMT1 is found at the apical membrane of renal tubular
cells (Ferguson et al., 2001; Canonne-Hergaux and Gros, 2002;
Veuthey et al., 2008). Wareing et al. (2000) demonstrated that a
signiﬁcant amount of iron is ﬁltered at the glomerulus and the
majority is reabsorbed along the nephron. There is evidence to
suggest that Tf-bound iron may be ﬁltered and reabsorbed along
the proximal tubule following endocytosis via themegalin–cubilin
pathway, a possible novel TfR, and/or the TfR1 (Kozyraki et al.,
2001; Smith andThevenod, 2009). These data support the hypoth-
esis that the kidney, in addition tomaintaining its self-supply, may
also undertake iron reabsorption and thus contribute to general
iron homeostasis (Figure 3). Furthermore, renal Fpn expression
in proximal tubule-speciﬁc ferritin heavy chain-knockout mice is
decreased, both in mRNA and protein levels (Zarjou et al., 2013).
Under normal conditions Fpn was predominantly expressed in
the apical membrane of proximal tubules, while after acute kid-
ney injury Fpn was redistributed to the cytosol and basolateral
membrane. This recent ﬁnding reinforces the hypothesis that kid-
ney may be more extensively involved in iron metabolism than
initially proposed.
DIVALENT METAL TRANSPORTER 1
DMT1, also known as Nramp2, DCT1, and SLC11A2, was iden-
tiﬁed in 1997 by two groups using different approaches. Gunshin
et al. (1997) uncovered the iron transporter by functional expres-
sion cloning and Fleming et al. (1997) determined that defects
in its gene were responsible for the microcytic anemia pheno-
type of mk mice. As outlined above, it is the major point of iron
entry into the body. DMT1 has 12 putative transmembrane (TM)
domains. Predicted glycosylation sites in the fourth extracellular
loop and a consensus transport motif in the fourth intracellular
loop were deﬁned, with both N- and C-termini determined to
be topologically situated within the cytoplasm (Gruenheid et al.,
1995; Gunshin et al., 1997). Three negatively charged and highly
conserved residues in TM 1, 4, and 7 of DMT1 are suggested
to be essential for cation transport. In addition, two histidine
residues in the TM domain 6 appear critical to normal function
(Lam-Yuk-Tseung et al., 2003). DMT1 selectively imports iron in
a pH-dependent manner and it has been described to operate as
a H+/divalent cation cotransporter (symporter) but also as a H+
uniporter. Another important feature is the voltage-dependent
activity of DMT1 gradient (Gunshin et al., 1997).
Transcription of the SLC11A2 genes encoding DMT1 origi-
nates four different mRNA transcripts, called 1A/+IRE, 1A/−IRE,
1B/+IRE, and 1B/−IRE. Alternate promoters determine whether
the 5′ end of the mRNA will be exon 1A or exon 1B (Hubert
and Hentze, 2002). Moreover, variable 3′ processing give rise to
two transcripts that differ in the 3′-translated and untranslated
regions (UTRs). One of the transcripts is referred as+IRE because
it contains an iron-responsive element (IRE) in its 3′-UTR, while
the other is called −IRE because it lacks that element (Lee et al.,
1998). The four transcripts encode related but distinct proteins.
Thus, +IRE and −IRE encode two isoforms that differ in the C-
terminus: an 18 amino acid residue found in the +IRE isoforms
while −IRE transcripts have a 25 amino acid residue.
The key difference between +IRE and −IRE transcripts is the
fact that the presence of the IRE confers post-transcriptional reg-
ulation by iron status. Similar to TfR regulation (Galy et al., 2013),
decreased iron supply promotes the interactions of the +IRE
DMT1 transcript with iron regulatory proteins (IRPs), resulting
in the stabilization of the mRNA (Gunshin et al., 2001; Pantopou-
los, 2004). This is one mechanism that accounts for the increased
duodenal expression of DMT1 seen under iron deﬁciency, thus
promoting iron uptake (Canonne-Hergaux et al., 1999). Another
mechanism is conferred by 5′ regions ﬂanking exon 1A,which con-
tain hypoxia response elements (HREs). In the intestine, HREs
are recognized by HIF-2α to modulate DMT1 expression under
hypoxic conditions (Mastrogiannaki et al., 2009; Shah et al., 2009).
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FIGURE 2 |The transferrin (Tf) cycle. Apo-Tf binds ferric iron. The
resulting Holo-Tf associates with TfR located on the cell surface. The
complex TfR–Tf–Fe is then internalized. Iron is released within endocytic
vesicles by a process that involves endosomal acidiﬁcation. Apo-Tf
remains bound to its receptor in the endosome and this receptor
complex recycles back to the cell surface. Ferric iron is reduced in the
endosome (Steap3), and then released into the cytosol by DMT1. The
G185R mutation of the Belgrade rat produces DMT1 that is defective in
this step, thus some iron remains bound to Tf and recycles back with
the receptor.
The isoforms also differ in the sites of expression. Whereas the
1B isoform is ubiquitous, the 1A isoform appears to be tissue-
speciﬁc. Expression of DMT1 1A isoform in duodenal enterocytes
has been reported by several authors, with a gradient of expres-
sion from the proximal to distal small intestine (Gunshin et al.,
1997; Canonne-Hergaux et al., 1999). The kidney is the tissue
with second highest expression of the 1A isoformmRNAof DMT1
(Hubert and Hentze, 2002). On the other hand, both +IRE and
−IRE isoforms are expressed in many tissues such as liver, lung,
brain, and thymus (Gunshin et al., 1997; Hubert and Hentze,
2002).
As the name implies, DMT1 is able to transport a broad spec-
trum of divalent metals, although its afﬁnity for Fe2+ is much
higher than for othermetals (Mackenzie andHediger, 2004).Man-
ganese, in particular, possesses many physicochemical properties
similar to iron, and both metals have been shown to compete
in membrane transport processes such as intestinal absorption
(Thomson et al., 1971; Rossander-Hulten et al., 1991) and uptake
by erythroid cells (Morgan, 1988; Chua et al., 1996). Like iron,
manganese is an essential nutrient, and exogenous expression
studies (Conrad et al., 2000; Garrick and Dolan, 2002), and more
recent molecular studies (Roth and Garrick, 2003; Thompson
et al., 2007b; Illing et al., 2012; Kim et al., 2012) have documented
a role for DMT1 in manganese uptake as well as iron trans-
port. Unlike iron deﬁciency, hypomanganesemia is rare. However,
manganese loading or manganism can be caused by excess metal
exposure resulting in a Parkinson-like disorder. Loading of this
metal is not typically associated with ingestion since hepatic ﬁrst-
pass elimination provides an important protective mechanism
against potential toxicity. Since intake of airborne Mn2+ bypasses
the biliary excretion route, distribution of metal directly to the
brain can occur, promoting neurotoxicity. Several studies have
demonstrated a strong relation between high levels of manganese
and impaired behavior (Yamada et al., 1986; Tran et al., 2002).
The role of DMT1 not only in iron pathophysiology but also in
manganese toxicity will be discussed below.
THE BELGRADE RAT
Belgrade (b) rats were described for ﬁrst time in 1966 as offspring
of an X-irradiated albino rat in Belgrade, Yugoslavia (Sladic-Simic
et al., 1966). No differences were observed in litters of F1 genera-
tion.When the female was bred with a normal male, 11 apparently
normal rats were born, four of which died young. Of the seven
remaining, two pairs were mated, producing anemic rats in the F2
generation. In subsequent ﬁlial generations anemic rats were also
seen, suggesting that offspring were heterozygous for a recessive
mutation that caused anemia.
The newborn anemic rats were pale, with growth retarda-
tion compared to normal littermates. Peripheral blood smears
showedmarkedmicrocytosis, anisocytosis, and poikilocytosis that
increased with age. Themean value for erythrocytes in the periph-
eral blood was signiﬁcantly decreased and a progressive decline in
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FIGURE 3 | Hypothetical model of renal iron handling. Filtered Tf–Fe is
reabsorbed in proximal tubule cells by receptor-mediated endocytosis.
Potential receptors include cubilin–megalin complex, a possible novel Tf
receptor (TfR), and TfR1. Reabsorption of iron bound to a chelator (LCN2)
has also been described, although the receptor involved is less clear.
Alternatively, ferrous iron is directly imported into the cell by DMT1.
Although several features of the model are not completely known, it has
been postulated that iron complexes could be endocytosed. Once in the
endosome, iron would be reduced and released into the cytosol by
endosomal DMT1. Finally, ferrous iron is exported by FPN located in the
basolateral membrane; an apical distribution has been noted under
conditions of renal failure.
FIGURE 4 | Belgrade rat. A b/b rat pup (foreground) and heterozygous +/b
littermate are shown at post-natal day 10. Image courtesy of Dr. Xuming Jia.
hemoglobin values occurred with age (Sladic-Simic et al., 1966).
Adult b/b rats are distinguished by lower body weight than +/b
rats (Thompson et al., 2007a), and characterized by pinkish retinal
reﬂex andwhite ears, in contrast with the bright red of+/b animals
(Ivanovic, 1997). Anemia was also accompanied by a decrease in
platelets count and leukocytosis (Ivanovic, 1997).
In the spring of 1967, a colony of these rats was brought to the
U.S. and established in NewYork (Sladic-Simic et al., 1969). It was
maintained by crossing Belgrade males with Wistar female rats.
Then, the F1 heterozygous females were back-crossed to homozy-
gous anemic males; some rats from the F2 generation exhibited an
anemic condition similar to that described in Belgrade rats. The
appearance of the phenotype in F2 generations was compatible
with a single autosomal recessive character, as previously demon-
strated in Belgrade (Sladic-Simic et al., 1969). This genetic factor
was designated as b and the homozygous anemic Belgrade rats
were called b/b (Figure 4).
It was nearly 30 years after the discovery of these rats that
detailed genetic characteristics of Belgrade rats were ascertained.
A glycine-to-arginine substitution (G185R) in the fourth TM
domain of DMT1 was reported, resulting in loss of activity of
the transporter (Fleming et al., 1998). Remarkably, it was the exact
same mutation reported for mk mice that led to the identiﬁcation
of DMT1 (Fleming et al., 1997). Despite the fact that increased
transcript levels are induced by iron deﬁciency, relative amounts
of protein are reduced (Oates et al., 2000; Yeh et al., 2000; Fergu-
son et al., 2003), and the function of residual DMT1may be altered
(Yeh et al., 2000; Touret et al., 2004; Xu et al., 2004). Work on the
Belgrade rat deﬁned a key role forDMT1not only in intestinal iron
absorption, but also in the Tf iron delivery cycle. In fact, Belgrade
rats can display high serum iron due to ineffective erythropoiesis
(Thompson et al., 2006).
Since the iron imbalance of b/b rats became known, many
attempts were made to relieve the anemia, extend lifespan and
improve husbandry of the Belgrade rat. Iron supplementation by
iron-dextran injections was ﬁrst tested, but although the anemic
state was improved, tissue iron deposition was observed (Gar-
rick et al., 1997). Iron supplementation by diet turned out to be
more beneﬁcial since it improved anemia without alteration in
red cell morphology. Although in both cases iron treatment raised
hemoglobin values, levels remained lower than control (Sladic-
Simic et al., 1966). Later on, it was reported that the critical
nutritional factor would be the source of iron, given that ferrous
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iron was more bioavailable than ferric iron (Sladic-Simic et al.,
1969; Garrick et al., 1997).
CHARACTERISTICS OF BELGRADE RAT ERYTHROID CELLS
The complexity of iron metabolism in Belgrade rats triggered
many questions about the mechanism underlying the impaired
utilization of iron. Since the anemia of b/b rats resembled tha-
lassemia in humans, ﬁrst thoughts were focused on possible
differences of hemoglobin characteristics. It was demonstrated
that reticulocyte globin synthesis was diminished in b/b rats
although no major imbalance between α- and β-chain produc-
tion was observed (Edwards et al., 1978). A lack of sideroblasts
was also observed in b/b rats, indicating that iron was not accu-
mulated within erythroid cells (Edwards et al., 1978). This ﬁnding
suggested a defect in iron transport into the erythroid cells rather
than a defect in intracellular utilization. To consider the possibility
that Belgrade rats harbored a defect in heme synthesis, iron incor-
poration into heme was inhibited. Iron uptake by reticulocytes
became diminished with no evidence of intra-erythrocyte iron
accumulation in b/b rats compared to controls (Edwards et al.,
1978). These data suggested that Belgrade anemia was probably
not due to a defect in heme synthesis. The same authors were ulti-
mately able to demonstrate that the main defect related to iron
utilization in b/b rats lies in a signiﬁcantly lower reticulocyte iron
uptake compared to +/b controls.
Each step in the iron uptake mechanism by reticulocytes was
studied in detail to decipher the underlying cause of Belgrade ane-
mia (Bowen andMorgan, 1987). When receptor interactions were
evaluated, Tf binding afﬁnities between b/b and control reticu-
locytes were found to be similar. The Tf molecule itself had the
same molecular weight and net charge compared to Wistar rat Tf
(Farcich andMorgan, 1992b). Studies on Tf endocytosis showed a
slower mechanism in Belgrade reticulocytes, although the relative
decrease was not as great as the defect in iron uptake. In addition,
Tf exocytosis ratewas similar betweenBelgrade and control reticu-
locytes, although b/b cells released more iron with Tf than control
cells (Bowen and Morgan, 1987). In fact, a signiﬁcant proportion
of the iron taken up by b/b reticulocytes returned to the extra-
cellular medium, concordant with reduced iron accumulation.
These early studies clearly indicated that Belgrade reticulocytes
were defective in iron release after uptake by Tf within endocytic
vesicles such that if ironwas released, it was unable to pass through
the endocytic vesicle membrane to the cytoplasm (Bowen and
Morgan, 1987; Figure 2).
Garrick et al. (1993b) focused on the Tf cycle to more deﬁni-
tively demonstrate that b/b reticulocytes retained only half of iron
borne by incoming Tf, while around 90% of iron that entered to
normal cells remained intracellular. This evidence conﬁrmed that
ineffective iron utilization by b/b reticulocytes contributes to the
Belgrade defect. Furthermore, when heme synthesis was inhibited,
iron from Tf failed to accumulate in the stromal (mitochondrial)
fraction or in the non-heme cytosolic fraction (Garrick et al.,
1993a). These studies reinforced the idea that the Belgrade defect
was related to iron release from Tf or its transport from endo-
cytic vesicles. The signiﬁcantly lower uptake of iron by erythroid
precursors most likely contributes to the increased Tf saturation,
serum total iron-binding capacity (TIBC) and serum iron levels
reported in b/b rats (Thompson et al., 2006). It was also reported
that Belgrade reticulocytes have only about half the amount of
globin mRNA compared to normal cells, suggesting some sort of
a translational defect (Chu et al., 1978). Given that heme regulates
mRNA translation in reticulocytes, the failure in this process could
be explained because b/b reticulocytes contain about 40% of “free”
heme compared to +/b cells (Garrick et al., 1999b).
Non-Tf-bound iron uptake by erythroid cells was also char-
acterized in Belgrade rats (Garrick et al., 1999a). NTBI uptake
differed from Tf–Fe uptake in the pattern of iron distribution
between subcellular fractions. Moreover, b/b cells only incorpo-
rated 20% of the NTBI compared to +/b cells, a fraction similar to
the residual levels found for Tf–Fe utilization. The results strongly
suggested that DMT1 could also play a key role in NTBI acquisi-
tion into heme, as well as in iron transport out of endosomes in
the reticulocyte Tf cycle. Since the relationship between iron and
manganese transport was recognized many years ago, the abnor-
mal iron metabolism seen in erythroid cells of b/b rats elicited
interest to determine if manganese transport was also affected.
Three manganese transport mechanisms have been identiﬁed in
reticulocytes, one for Mn–Tf and two for the unbound divalent
cation Mn2+, one of low and the other of high afﬁnity (Chua
et al., 1996). Impaired manganese uptake from Tf and defective
import via the high afﬁnity Mn2+ transport were both observed
in Belgrade reticulocytes. These ﬁndings strongly supported the
idea that these two pathways utilize the same transporter (Chua
and Morgan, 1997).
Several studies sought to gain deeper insight into hematopoi-
etic function in Belgrade rats. Homozygous rats display decreased
general cellularity in bone marrow than normal rats. For exam-
ple, early and late erythroid progenitors (BFU-E and CFU-E;
Pavlovic-Kentera et al., 1989), granulocyte–monocyte progenitors
(Stojanovic et al., 1990), and megakaryocyte progenitors (Rolovic
et al., 1991) are signiﬁcantly diminished. In addition, intensive
splenic hematopoiesis has been described in b/b rats, indicated
by increased iron uptake by spleen, expression of erythroid dif-
ferentiation markers and elevated erythropoietin serum levels
(Pavlovic-Kentera et al., 1989; Biljanovic-Paunovic et al., 1992;
Ivanovic, 1997). Indeed, while 42-day-old +/b rats have a spleen
weight fraction of 0.32 ± 0.1, age- and diet-matched b/b rats have
a spleen weight fraction of 1.50 ± 0.13 (both values are % body
weight; n = 3–4; P < 0.05; J. Kim and M. Wessling-Resnick,
personal observations).
DUODENAL ABSORPTION OF IRON AND MANGANESE
Early studies by Morgan’s group (Farcich and Morgan, 1992a)
demonstrated reduced intestinal iron absorption by Belgrade
rats, a key ﬁnding supported by later work from several groups
under different experimental conditions (Knopfel et al., 2005b;
Thompson et al., 2007a). Since duodenal iron absorption is highly
regulated by iron status, Morgan and colleague also characterized
absorption by Belgrade rats fed diets of normal, low, and high iron
content (Oates and Morgan, 1996). While duodenal iron uptake
in control +/b rats varied inversely with iron intake, b/b rats failed
to show changes under iron loading or iron deﬁciency. It was later
shown that a bolus of dietary iron could induce a rapid decrease
in intestinal DMT1 mRNA in +/b and b/b rats (Yeh et al., 2000).
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In addition, this study showed that b/b rats had generally higher
basal protein levels of DMT1. Itwas also observed that b/b rats have
lower duodenal DMT1 protein than expected based on the higher
mRNA levels, possibly due to impaired release of the mutant pro-
tein from its site of synthesis or accelerated degradation (Morgan
and Oates, 2002). Finally, TfR gene expression and Tf-bound iron
uptake by duodenal enterocytes also has been investigated in the
Belgrade rat. TfR1 mRNA expression in b/b epithelial cells of the
crypt region and crypt–villus junction and 125I-labeled Tf uptake
in b/b villus cells were both similar toWistar rats, while uptake was
signiﬁcantly greater in b/b crypt cells (Oates et al., 2000). These
observations suggest that uptake of Tf by enterocytes is largely
independent of DMT1’s activity, while it remains unknown if iron
delivery by Tf to these intestinal cells might be affected in the
Belgrade rat.
Molecular studies on the G185R mutant of DMT1 have shown
that transfected cells will target the protein product to the plasma
membrane and endosomes although levels are lower than wild-
type at the cell surface (Su et al., 1998; Touret et al., 2004). These
studies have suggested the mutant has reduced residual activity.
Whether the Belgrade rat survives on this reduced activity, or if
some other mechanism compensates for iron absorption has been
studied (Yeh et al., 2011). Gene expression studies showed HIF-2α
expression was increased in b/b rats compared with +/+ rats with
greater expression in the villus compared to crypt, a response that
correlated with the presence of hypoxic protein adducts. Under
hypoxic conditions, compounds as nitroimidazole or some of its
derivatives, enter viable cells and interact with thiol groups of
intracellular proteins thus forming the adducts. Under normal
oxygen levels the compounds are reoxidized and diffuse out of the
cells.
Moreover, most of the genes whose protein products are
responsible for duodenal iron transport were up-regulated. One
factor that did not increase was ZIP14, suggesting that it is unlikely
to compensate for iron absorption (Yeh et al., 2011). There may be
other parallel uptake pathways for iron, however. This idea is sup-
ported by studies of neonatal iron assimilation in Belgrade pups.
After administration of 59Fe to lactating foster dams, total levels
of assimilated 59Fe between suckling b/b and +/b pups were not
different. However, the examination of blood compartments in
b/b pups showed elevated iron levels in serum and reduced levels
in RBCs compared to +/b siblings. Tissue iron distribution was
signiﬁcantly higher in heart, kidney, liver, spleen, and intestine
in homozygous pups (Thompson et al., 2007a). Thus, during lac-
tation iron absorption occurs normally, but delivery to red cells
is impaired in b/b rats causing apparent iron loading in other
peripheral tissues. Later on, iron absorption is impaired in adult
Belgrade rats as discussed above. Thus, DMT1 does not appear to
play a signiﬁcant role in iron assimilation during lactation, but a
developmental transition to DMT1-mediated iron uptake occurs
as food intake begins. What factors mediate iron absorption in
early development remain to be better characterized, butmay pro-
vide some clues to additional mechanisms that could compensate
for the intestinal uptake defect in the Belgrade rat.
Belgrade rats have also been used to study duodenal trans-
port of manganese and the role of DMT1. Chua and Morgan
(1997) evaluated manganese absorption from the intestine using
closed in situ loops of duodenum and distinguishing between
uptake, transfer, and absorption.Manganese uptakewas decreased
in b/b rats compared to +/b rats. Although manganese trans-
fer from the duodenum into the carcass was similar in both
genotypes, the percentage of absorption in homozygous rats was
signiﬁcantly low. Hence, the primary defect appears to be the
absorption step responsible for the uptake of manganese from
the gut lumen implicating DMT1 in this process. Indeed, stud-
ies from our own laboratory have indicated that Belgrade rats
have lower blood manganese levels, supporting the idea that they
have manganese as well as iron deﬁciency. Levels of manganese
are 14.6 ± 2.3 versus 8.1 ± 1.2 ng/g blood in +/b versus b/b rats
(±SEM, n = 7, P = 0.0029; J. Kim and M. Wessling-Resnick,
personal observations).
HEPATIC HANDLING OF IRON AND MANGANESE
Iron accumulation in tissues of b/b rats after parenteral iron
administration was reported early on in the characterization of
the Belgrade phenotype (Sladic-Simic et al., 1969). In fact, this
feature defect resembled thalassemia, an iron-loading anemia.
When the ﬁrst humanmutations inDMT1were discovered (Mims
et al., 2005; Beaumont et al., 2006; Lam-Yuk-Tseung et al., 2006),
patients were found to suffer not only from anemia but also
from hepatic iron overload. It was suggested that rodent mod-
els of DMT1 deﬁciency did not display iron overload since heme
iron was not present in chow, and that the human condition
might be caused up-regulation of heme absorption. Our labora-
tory investigated this issue in the Belgrade rat model (Thompson
et al., 2006). First, female +/b rats crossed with male b/b rats were
fed an iron-supplemented diet (500 ppm) to support pregnancy.
After birth, litters were cross-fostered to F344 Fischer dams fed
a standard diet, and upon weaning both +/b and b/b pups were
fed an iron-supplemented diet 3 weeks. To control for the ane-
mic status of the Belgrade rats, +/b rats are fed a low iron diet
(5 ppm) under our laboratory’s husbandry protocol (Figure 5).
Despite the anemic state of b/b rats, liver non-heme iron con-
tent was greater compared with age-matched (and diet-matched)
+/b sibling controls. Perl’s Prussian blue staining showed iron
deposition was evident in both periportal and centrilobular zones.
In contrast, no iron staining was observed in age-matched +/b
rats (Thompson et al., 2006). This pattern of liver iron deposi-
tion suggested that the primary defect in erythron iron utilization
seen in homozygous rats leads to liver iron loading. Consistent
with this idea, the Belgrade rats also display higher serum iron
levels (Kim et al., 2013). These data argue that the liver can
acquire iron independent of DMT1, in agreement with previ-
ous studies that showed iron-loading in DMT1 knockout mice
(Gunshin et al., 2005). The high hepatic expression of Zip14 –
which is up-regulated by high iron (Nam et al., 2013) – raises the
likelihood that this transporter is responsible. Interestingly, quan-
titative real-time RT-PCR analysis showed hepcidin expression
was threefold higher in b/b compared to +/b littermates (Thomp-
son et al., 2006), consistent with studies showing that hepcidin
expression increases with liver iron loading despite severe anemia
(Vokurka et al., 2006). Yeh et al. (2011) have also reported hep-
cidin expression increases in iron-fed b/b rats. Thus, the Belgrade
rat’s inability to take up adequate iron might be compounded
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FIGURE 5 | Breeding and maintenance of the Belgrade rat.
by hepcidin’s down-regulation of ferroportin, the basolateral iron
exporter. Recent studies in mice with the Dmt1 gene selectively
inactivated in hepatocytes reinforce the idea that hepatic DMT1
is dispensable for NTBI uptake, although they also showed unaf-
fected hepatic iron levels in these mice, suggesting that DMT1
is also not essential for hepatic iron accumulation (Wang and
Knutson, 2013).
Manganese as well as iron content is altered in liver of Bel-
grade rats. It has been reported that the concentration and total
content of manganese in liver is signiﬁcantly less in b/b rats com-
pared to +/b rats (Chua and Morgan, 1997). As discussed above,
intestinal manganese absorption is diminished in Belgrade rats.
Interestingly, a signiﬁcantly higher uptake of 54Mn into liver was
observed when it is administered as Mn–Tf or Mn–serum (Chua
and Morgan, 1997). The difference between iron and manganese
metabolism is that while iron is retained, and therefore might
accumulate due to ineffective erythroid uptake, excess manganese
is rapidly cleared by the liver (Papavasiliou et al., 1966). The fact
that hepatic uptake is increased suggests the liver import mech-
anisms of these two metals once again overlap: up-regulation of
Zip14 or another transporter might induce this effect.
RENAL IRON HANDLING
Despite the high renal expression of DMT1, we only have a min-
imal understanding of its function in this tissue. Studies of the
renal physiology of Belgrade rats have helped to shed some light.
Analysis of renal DMT1mRNA showed the same transcript size in
b/b and +/b rats, without changes in levels of mRNA expression
between genotypes (Ferguson et al., 2003). Expression of DMT1
protein is reduced in the kidneys, but this might be expected since
protein levels do not generally reﬂect transcript levels. Reduced
immunostaining for DMT1 was not speciﬁc for a region, since
it is observed in proximal, distal, and collecting tubules. Once
again, these observations indicate that themutationmay accelerate
DMT1 degradation or cause defective posttranslational processing
(Ferguson et al., 2003).
General tissue disorganization and abnormal morphology of
cortical tubules of the Belgrade rat kidney was ﬁrst noted by
Ferguson et al. (2003). A later study from our group described
glomerulosclerosis and interstitial sclerosis in b/b rats upon aging,
with ﬁbrosis in glomeruli and areas of tubulointerstitial ﬁbrosis
(Veuthey et al., 2013). Tubular dilation with ﬂattened epithelium
in some cortical tubules andocclusionof the luminal space in other
cases was observed. Although serum creatinine appears normal in
b/b rats, creatinine clearance was signiﬁcantly reduced suggesting
a decrease in the glomerular ﬁltration rate. Moreover, elevated
urinary albumin in b/b compared to +/b rats has been reported
by us (Veuthey et al., 2013), suggesting damage in the glomerular
membrane (Satchell and Tooke, 2008). Since albumin is normally
reabsorbed in the tubular system, the evidence suggests that the
increased tubular burden of albumin could be associated with
progressive interstitial ﬁbrosis and tubular damage (Eddy, 1994;
Jerums et al., 1997; Wang and Hirschberg, 2000).
A detailed measurement of several electrolytes has been carried
out in feces, serum, and urine of Belgrade rats (Ferguson et al.,
2003). Fecal excretion of almost all tested ions was similar between
b/b and +/b animals, except for Fe2+, which was higher in b/b
rats. In addition, serum levels of electrolytes showed high Mg2+
and decreased K+ in b/b compared to +/b rats. Urinary analysis
revealed higher Ca2+ levels but without changes in Fe levels. This
last ﬁnding differs from studies of the Belgrade rat in our lab that
show higher urinary iron output; the age of rats that were studied
could be one factor accounting for this difference since kidney
functionworsens with age in Belgrade rats (Jia et al., 2013;Veuthey
et al., 2013). The fact that more iron is excreted in b/b rat urine
could result from the altered glomerular membrane function, but
also from loss of tubular reabsorption. Evidence suggests that both
pathways could be affected in b/b rats (Veuthey et al., 2013). Since
tubular uptake of Fe3+ bound to Tf seems to be mediated by
cubilin, the high urinary Tf seen in b/b together with the absence
of changes in cubilin suggest that tubular reabsorption of Tf is not
affected.
www.frontiersin.org April 2014 | Volume 5 | Article 82 | 7
Veuthey andWessling-Resnick The Belgrade rat
Another interesting ﬁnding related to the renal pathology was
the premature death of homozygous Belgrade rats. We observed
that several early urinary biomarkers of renal injury were altered
b/b rats, pointing to a kidney defect (Veuthey et al., 2013). The
evaluation of early renal development in b/b pups by the radial
glomerular count (RGC) method supports the idea that limited
iron supply during early life could affect renal development in
adults leading to injury and even death from renal failure (Drake
et al., 2009; Veuthey et al., 2013). Maternal iron restriction dur-
ing pregnancy has been previously documented to induce altered
renal morphology in adult offspring (Lisle et al., 2003). Nephron
number is set early in life and does not increase (Al-Awqati and
Preisig, 1999). Our RGC study of nephrogenesis indicated that b/b
pups have decreased nephron allotment. Brenner et al. (1996) have
put forward the hyperﬁltration hypothesis that these early devel-
opment defects explain compromised renal metabolism observed
in adulthood. Adaptive activity of remnant nephrons would need
to maintain glomerular ﬁltration. Over time, increased glomeru-
lar pressure promotes ﬁbrosis and sclerosis to produce glomerular
injury. Such injury leads to further nephron loss, thereby contin-
uing a vicious cycle that ﬁnally decreases the glomerular ﬁltration,
ending in renal damage and poor kidney function.
RESPIRATORY AND OLFACTORY UPTAKE
Due to the nature of its transport and metabolism, airborne man-
ganese promotes neurotoxicity upon its distribution to the brain.
Inhalation exposures tomanganese pose a signiﬁcant occupational
health risk to welders, for example, who are exposed to fumes
containing iron, chromium, manganese, aluminum, nickel, and
cadmium.Within thesemixtures aremultiple transport substrates
for DMT1. Our laboratory was interested in the potential role
DMT1 played in this process due to the fact this pathway would be
up-regulated during iron deﬁciency. “Iron-responsive manganese
uptake” would exacerbate the neurotoxicity of airborne metal.
Here, the Belgrade rat was used as a model system, with cohorts
of homozygous, heterozygous, and anemic heterozygous controls
(Figure 5). Uptake of intranasally instilled 54Mn was markedly
reduced in b/b rats compared to iron-replete +/b rats (Thompson
et al., 2007b). Enhanced 54Mn absorption was observed in iron-
deﬁcient +/b controls relative to both b/b and iron-replete +/b
rats. In contrast, 54Mn clearance from blood to peripheral tissues
showed the same pharmacokinetics for intravenously injected b/b,
+/b and iron-deﬁcient +/b rats. The sum of this pharmacokinetic
data supports a functional role for uptake of DMT1 in manganese
uptake by the olfactory pathway. Immunohistochemistry revealed
that DMT1 was associated with the microvilli of the olfactory
epithelium and the endfeet of olfactory epithelial sustentacular
cells. Most importantly, DMT1 levels in the olfactory epithelium
were signiﬁcantly greater in iron-deﬁcient rats. Finally, the fact that
total levels of Mn in brain of intranasally instilled rats were 10-fold
higher than in intravenous injected animals directly demonstrates
that inhalation promotes greater brain manganese uptake. Thus,
the apparent function of DMT1 in olfactory Mn absorption sug-
gests that manganese neurotoxicity can be modiﬁed by iron status
due to the iron-responsive regulation of DMT1. Subsequent stud-
ies of the Belgrade rat also showed that lack of DMT1 can affect the
absorption of iron from the nasal cavity to the blood and ﬁnally
to the brain (Ruvin Kumara andWessling-Resnick, 2012), further
localizing iron-regulated DMT1 expression in the olfactory bulb,
too.
The Belgrade rat also has been used to investigate whether
DMT1 plays a role in uptake across the pulmonary epithelium
of the lungs. Previous investigation by others showed the Bel-
grade rat has reduced clearance of iron (Wang et al., 2002). In our
intratracheal instillation experiments, the transport of 54Mn to
the blood was unaltered (Brain et al., 2006). However, studies of
the Belgrade rat do suggest that DMT1 is involved in pulmonary
inﬂammation (Wang et al., 2005; Kim et al., 2011) as well as metal-
induced injury (Ghio et al., 2005,2007), emphasizing an important
detoxiﬁcation pathway that can transport and sequester metals in
the lungs after inhalation exposures. Using the Belgrade ratmodel,
Ghio and colleagues demonstrated that ozone-induced lung injury
was dependent on DMT1 and that the transporter could modify
oxidative stress responses. Lipopolysaccharide (LPS) also has been
shown to induce DMT1 (Nguyen et al., 2006), supporting that
idea that under infection and inﬂammation, it functions to take
up and sequester metals as a protective host response. The net
effect of such alterations would be to reduce levels of manganese
available in the lung to limit survival of pathogens like S. pneu-
monia and to help protect the lungs from inﬂammation due to air
pollution and other irritants.
THE BLOOD–BRAIN BARRIER
Brain metal homeostasis is critical to cognitive development,
behavior, and motor control. Excess iron and manganese are also
associated with neurodegeneration, for example, in Alzheimer’s
and Parkinson’s disease patients. Belgrade rats have been used
to study transport of iron and manganese across the blood–
brain barrier. Iron content in brain seems to vary depending
on the age of b/b rats. Similar levels were reported for b/b and
+/b pups, while signiﬁcantly lower levels were seen in 21-day-
old b/b rats compared to +/b age-matched controls (Thompson
et al., 2007a). Burdo et al. (1999) performed a detailed analy-
sis of iron distribution in brain of Belgrade rats. Cortical gray
matter showed iron-positive astrocytes in brain of both b/b and
+/b rats, although fewer cells were stained in the Belgrade rat
cohort. Iron was also observed in pyramidal neurons, but they
were fewer in number and less intensely stained than in +/b
rats. In white matter of +/b rats, iron was present in patches
of intensely iron-stained oligodendrocytes and myelin, while the
same pattern of expression was seen but with dramatically less
intensity in homozygous rats. In addition, the stained oligoden-
drocytes were associated with blood vessels. The general decrease
in iron staining observed in b/b rats compared to +/b is consistent
with the decreased Tf and iron uptake into the brain previously
reported for Belgrade rats (Farcich and Morgan, 1992a). Loss of
neuronal iron staining in brain of b/b agrees with the ﬁnding that
DMT1 mRNA is mainly expressed in these cells (Gunshin et al.,
1997).
Early in 1992, impaired iron uptake by b/b rat brain was
reported, although at that time the details of this mechanism were
not clear (Farcich and Morgan, 1992a). Later on, it was estab-
lished brain uptake of Tf-bound iron was decreased in young and
adult b/b rats compared to +/b control rats, while Tf uptake was
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similar between both cohorts (Moos and Morgan, 2004). These
authors also reported signiﬁcantly lower iron content in brain of
b/b rats together with higher expression of neuronal TfR1, con-
ﬁrming the iron-deﬁcient stage of homozygous rats. By looking at
the brain capillary endothelial cells (BCECs) involved in the trans-
port trough the blood–brain barrier, TfR expression appeared to
be identical. DMT1 was mainly detected in the cytoplasm of neu-
rons and choroid plexus epithelial cells, but was not detected in
BCECs (Moos and Morgan, 2004).
Based in that study, it has been proposed that neurons could
acquire iron by receptor-mediated endocytosis of Tf, followed by
iron transport out of endosomes mediated by DMT1. In Belgrade
rats, the mutation on DMT1 could explain the low cerebral iron
uptake, suggesting that it is due to a reduced neuronal uptake
rather than an impaired transport trough the blood–brain bar-
rier. For manganese, however, the story is much less clear. Uptake
of intravenously injected 54Mn into the brain was similar for
b/b and +/b rats, while iron-deﬁcient +/b controls took up less.
Since presumably both TfR and DMT1 would be up-regulated
in the latter cohort, these data suggest the pathway for man-
ganese may be different than iron uptake into the brain. This
evidence agrees with previous reports that DMT1 is not involved
in the blood–brain transport of manganese (Crossgrove andYokel,
2004).
LIPID METABOLISM
Belgrade rats also exhibit pathological changes in lipid
metabolism. Homozygous b/b rats display hypertriglyceridemia
and elevated free fatty acids compared to +/b rats, without signif-
icant changes in cholesterol levels (Kim et al., 2013). Lipoprotein
triglycerides (TGs) are associated with very low density lipopro-
tein (VLDL). Since hepatic TG levels were similar in b/b and
+/b rats, higher serum TG levels in b/b rats appear to be unre-
lated to increased production, an idea supported by the fact that
hepatic lipogenic gene expression is not affected. Instead, all
of the evidence points to a block in TG uptake, which can be
explained by the fact that serum lipoprotein lipase (LPL) activity
is signiﬁcantly reduced in b/b rats compared to +/b age-matched
controls (Kim et al., 2013). LPL is the key enzyme responsi-
ble for release of TG lipids for uptake after VLDL binds to its
receptor. The fact that VLDL receptor levels in muscle [and low-
density lipoprotein (LDL) receptor levels in liver] are similar in
b/b and +/b rats supports the idea that LPL inhibition accounts
for hypertriglyceridemia. The unusual iron-loading anemia of
the Belgrade rat suggested an interaction with high serum iron.
Indeed, serum LPL activity is also reduced in rats with dietary
iron loading, conﬁrming the fact that increased serum iron is
associated with decreased LPL activity. Based on these data, our
laboratory studied how iron alters serum LPL ex vivo or recom-
binant LPL in vitro, ﬁnding that exogenously added iron inhibits
this enzyme in a dose-dependentmanner. These independent lines
of evidence suggests that elevated serum iron levels of b/b rats
promote reduced TG clearance due to LPL inhibition, resulting
in higher levels of serum TG. Although the molecular basis for
iron-mediated regulation of LPL activity is not clear, oxidative
modiﬁcation of the enzyme, its substrate, and/or reaction prod-
ucts could interfere with lipolysis (Kim et al., 2013). Clinically,
reduction of iron loading in patients by phlebotomy (Casanova-
Esteban et al., 2011), chelation (Cutler, 1989) and diet (Cooksey
et al., 2010) can help to improve lipid disorders. We also found
that reducing serum iron in Belgrade rats by treatment with the
uptake inhibitor ferristatin II improved their TG levels, suggest-
ing pharmacological interventions could be helpful (Kim et al.,
2013).
GLUCOSE METABOLISM
Despite their hyperferremia, Belgrade rats display normal insulin
and glucose tolerance (Jia et al., 2013). Comparable levels of
insulin-induced Akt phosphorylation in b/b and +/b rats suggests
that downstream insulin signaling is also unaffected. Moreover,
insulin secretory capacity of the pancreas showed no signiﬁcant
differences between b/b and +/b rats, although pancreatic non-
heme iron levels were>5-fold higher in Belgrade rats. Histological
evaluation suggests an absence of tissue damage despite the known
association between high serum iron and tissue damage (Inoue
et al., 1997). The sum of these data support that loss of DMT1
protects pancreatic β-cells and helps to maintain insulin sensitiv-
ity despite iron overload (Jia et al., 2013). These results correlate
very well with studies of the β-cell speciﬁc Dmt1 knockout mouse,
which is resistant to diabetes (Hansen et al., 2012).
An unusual characteristic of Belgrade rats is that they consume
more food that heterozygous littermates but display lower body
weight, suggesting an apparent imbalance in energy metabolism
(Ferguson et al., 2003; Jia et al., 2013). That unexpected pheno-
type has been associated, at least in part, with increased urinary
glucose excretion. Since the kidneys play an important role in
glucose homeostasis through tubular reabsorption, the glyco-
suria observed could be explained by the abnormalities reported
in kidney histology and physiology discussed above (Jia et al.,
2013; Veuthey et al., 2013). Collectively, these surprising ﬁndings
reveal that lack of DMT1 function could have an unexpected and
signiﬁcant role in energy balance.
TRANSPORT OF OTHER METALS
As its name implies, DMT1 not only services iron and manganese
metabolism, but it is also involved in uptake of other metals.
Knopfel et al. (2005b) isolated brush border membrane (BBM)
vesicles to study nickel transport in Belgrade rats. This group
measured active nickel transport in BBM vesicles from +/b rats
but not b/b rats. This result implies that the Belgrade mutation
disables the transport capacity for this metal. The potential role
of DMT1 in copper transport also has been evaluated using the
same approach. When unenergized vesicles were utilized, trans-
port of copper was disrupted in BBM vesicles isolated from b/b
rats, while +/b vesicles showed normal copper transport (Knopfel
et al., 2005a). Interestingly, when ATP-loaded or energized vesicles
were studied, transport characteristics for this metal appeared to
be identical in b/b and +/b rats. It was suggested that ATP-driven
copper uptake is a principal copper transport mechanism, while
DMT1 might act under conditions of copper excess. Since Bel-
grade rats are not copper deﬁcient despite DMT1 mutation and
iron deﬁciency, this evidence agrees with previous reports suggest-
ing the existence of several copper transporters other than DMT1
in the intestinal BBM (Knopfel et al., 2005a).
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However, the inﬂuence of copper in iron metabolism, and
reciprocally, the inﬂuence of iron status on copper metabolism,
presents an interesting and compelling relationship (Yokoi et al.,
1991; Ece et al., 1997). Induction of the duodenal Menkes copper
ATPase (Atp7a) and metallothionein (Mt1a) have been described
in iron-deﬁcient rats, togetherwith high serumandhepatic copper
levels and increased ceruloplasmin (Collins et al., 2005). Whether
or not DMT1 could contribute to copper uptake remains contro-
versial, with evidence for (Arredondo et al., 2003; Espinoza et al.,
2012) and against (Illing et al., 2012; Shawki et al., 2012). More-
over, the valency of copper as a potential transport substrate (Cu+
versus Cu2+) must be considered. Jiang et al. (2013) addressed
some of these questions using the Belgrade rat model by com-
paring b/b rats with diet-matched +/b and anemic +/b littermate
controls (Figure 5, for example). Previous work by this group
showed Belgrade rats did not display the expected changes in
hepatic or serum copper upon iron deﬁciency, suggesting DMT1
might play a role in these processes (Jiang et al., 2011). To test this
more directly, an everted gut sac transport assay was used to assess
Cu+ transport. Increased uptake in iron-deﬁcient+/b control rats
was observed while b/b and diet-matched+/b controls had similar
levels of uptake. Thus, DMT1 could play a role in copper uptake
under iron-deﬁciency conditions.
Interestingly, DMT1 demonstrates a stronger selectivity for
Cd2+ than Fe2+ or other more physiologically relevant metals
(Illing et al., 2012). This toxic metal is absorbed by the intestine
and other tissues and can exert nephrotoxicity. The notion that
DMT1might play a role in Cd distribution and uptake remains to
be tested – and the Belgrade rat may provide an excellent model
system to explore this possibility.
CONCLUSION
Although murine models are perhaps more often used to study
mammalian metabolism, rat models have provided critical infor-
mation about obesity (Zucker fatty rat), diabetes (Wistar fatty
rat; Otsuka Long–Evans Tokushima fatty rats; Goto-Kakizaki rat);
hypertension (Spontaneously hypertensive rat; Dahl salt-sensitive
rat), copper metabolism (Long–Evans cinnamon rat), and renal
metabolism (ZSF1 rat).Wehave outlinedmultiple exampleswhere
the Belgrade rat, as a model of iron deﬁciency, has been use-
ful in characterizing not only the role of DMT1 in transport
of this metal, but also its contribution to pathologies of inter-
mediary metabolism, its protective role in detoxiﬁcation of the
lungs, its participation in neurotoxicity of airborne metal uptake
by the olfactory pathway, in the development of the kidneys,
in promoting altered renal function, in brain iron metabolism
and in hepatic iron handling. While the Belgrade rat is the ﬁrst
known rat model of inherited anemia, recently Bartnikas et al.
(2013) described a rat model of hereditary hemochromatosis.
This group suggests that rats homozygous for a novel Ala679Gly
allele of the TfR2 gene spontaneously load iron, thus recapit-
ulating the human disease. Although many murine models of
hemochromatosis exist, none exhibit ﬁbrosis of the liver, a debil-
itating aspect in human patients with this disease. This opens
the exciting possibility to explore new metabolic features associ-
ated with inherited iron overload with the potential to explore
therapeutic avenues that will ameliorate the disease. Moreover,
as genetic manipulation of the rat becomes more routinely avail-
able, future models may contribute a better understanding of the
genes of iron metabolism – in both iron deﬁciency and over-
load – and their contributions to mammalian physiology and
pathology.
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